Miraculins Buys SCOUT DS Technology From VC-Backed Veralight
Winnipeg, Manitoba-based medical diagnostic company Miraculins Inc. has agreed to acquire all assets related to the SCOUT DS® technology, a diabetes screening technology, from VeraLight, Inc. Financial terms of the proposed deal were not released. VeraLight, which is based in Albuquerque, New Mexico, is backed by a mix of U.S. venture capital firms and strategic investors, including Psilos Group, CMEA Ventures, vSpring Capital, EPIC Ventures, Dow Chemical and the Southern Ute Growth Fund.
15 April 2013•5 mins read
